Teladoc Health to Announce First-Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Needham & Company Starts Teladoc (TDOC) at Buy
April 15, 2021 5:38 AM EDTNeedham & Company analyst Ryan MacDonald initiates coverage on Teladoc (NYSE: TDOC) with a Buy rating and a price target of $235.00.
The analyst comments "While Teladoc's market-leading position placed the company in a prime position to benefit from the pandemic-driven surge in adoption of... More
